What's New in Health and Life Sciences

News from the European Comission

EUROPA - Research and Innovation: Health & Life Sciences

EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Biosociety web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
Image of hand with a red heartEU-funded researchers have developed and tested a way to make human heart valve implants more tolerable and longer lasting, enabling recipients of all ages to avoid follow-up surgery and live largely normal lives, cutting hospital stays and healthcare costs.
Picture of a woman standing on a scalesEU-funded researchers have achieved a deeper understanding of how microbes in the gut can influence energy balance and behaviour. This could lead to new ways of tackling weight gain, eating disorders and even psychiatric conditions such as anxiety and depression.
Picture of the field trials with spelt, plot and different genotypesMinor species of cereals - such as spelt, oat and rye - could provide European consumers with healthy, nutritious food that is sustainably produced. An EU-funded project is looking to bring these underused crops from farm to table by improving their genetic and commercial viability.
Picture of the orchardIncreasing global trade and climate change have helped the spread of non-native pests and diseases across Europe, posing major challenges to plant health. The EU-funded Dropsa project is working with 26 partners in Europe, Asia, New Zealand and North America to find safe and sustainable ways to protect Europe's fruit industry.

DG Research & Innovation invites you to take part in the two interactive sessions organised at the European Health Forum Gastein.

    • Workshop on 4 October: "Personalised healthcare: How rare diseases pave the way", will focus on rare diseases research and care in Europe, the use of "omics" & Real-World Data, health data infrastructures and health data policy. • Session on 5 October: "Environment & Health: Building the evidence base for policy", will highlight the important role research plays in establishing and maintaining a strong evidence base for policy-making in the steadily evolving area of environment and health.

The big data revolution promises transformational potential for healthcare through data-driven improvements in research & development, care delivery, and policy-making.

As health systems around the world routinely collect a wealth of data every day, we are facing the question: how can we use big data to improve patient’s lives?

In a public lecture, Dr Jem Rashbass (National Director Disease Registration and Cancer Analysis at Public Health England) will outline how health systems can turn big data into information.

A high-profile panel will comment on how this information ca be put to use, implications of big data for healthcare system transformation, and patients’ perspectives on the collection and use of highly personal data.

Photo of a doctor holding a plastic heart surrounded by virtual emoticons of medical symbolsAn EU-funded project is carrying out the first clinical trial among elderly cardiac patients of a novel multi-medication pill to prevent recurrent heart attacks, improve the efficacy of care and save lives.
An EU-funded project is exploring techniques to produce key ingredients required for pharmaceuticals through more efficient, cost-effective and environmentally friendly processes.
Picture of woman with colorectal cancerEU-industry funded researchers have worked to identify and characterise signs of cancer, particularly colon cancers, and patients' responses to different types of treatment. The aim is to help doctors choose the best possible treatment for an individual patient's condition, potentially improving and saving lives.
Image of multicolored medical pillsEU and industry-funded researchers have gathered data on new biological indicators that could help to identify - accurately and early - the potential side effects of certain drug treatments. The research could help speed up drug development and improve diagnoses and patient care.
Picture of smiling African black man taking pills from the doctorEurope has identified the need for a central, standardised stem cell repository providing researchers with access to quality controlled cell lines and data for future drug development. EU and industry funding helped this new bio-bank facility establish initial operations and create a 'foundational collection'.
Picture of smiling African black man taking pills from the doctorEU and industry-funded researchers have developed a portable device to test in the field whether a person has caught the deadly Ebola disease. It gives reliable results in 75 minutes, which can help contain outbreaks and save lives.
Medical-imaging technologies have revolutionised healthcare, enabling doctors to safely peer deep inside the human body to diagnose disease. The EU-funded BE-OPTICAL project is helping to train the next generation of researchers in the field, contributing to the development of even more advanced life-saving imaging systems.

The European Research Infrastructure for Translational Medicine (EATRIS) organises its third bi-annual conference, “Translational Medicine 2017” on September 24-26 2017 at the Corinthia Hotel in Prague.

This event, open to a wide range of stakeholders from academic researchers, funders to industry players and regulators, will bring together international experts to discuss the latest advancements in translational medicine.

The theme of this third edition, “Enhancing Predictivity in Medicines Development” will focus on bringing together the latest technologies to increase success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification.

The TREGeneration partners

Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

Paul Ehrlich Institute approves cGVHD Trial Read more

Social Media

LinkedIn TREGeneration